Xanthone analogs for the treatment of infectious diseases

Methods of inhibiting the growth of protozoan parasites are disclosed. The methods comprise contacting the protozoan parasites with compositions comprising xanthones or xanthone derivatives such as 2,3,4,5,6-pentahydroxyxanthone. The invention includes th

Saved in:
Bibliographic Details
Main Authors HINRICHS DAVID J, WINTER ROLF WALTER, RISCOE MICHAEL KEVIN
Format Patent
LanguageEnglish
Published 04.04.2001
Edition7
Subjects
CHEMISTRY
GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE
Online AccessGet full text

Cover

More Information
Summary:Methods of inhibiting the growth of protozoan parasites are disclosed. The methods comprise contacting the protozoan parasites with compositions comprising xanthones or xanthone derivatives such as 2,3,4,5,6-pentahydroxyxanthone. The invention includes th
Bibliography:Application Number: AP19980001346